Optimizing Biopharmaceutical Manufacturing with AI
A Case Study on ADMAlytics™
powered by mcube™
Abstract
This paper discusses the transformative impact of ADMAlytics™, an AI-driven platform powered by mcube™, on the biopharmaceutical manufacturing processes at ADMA Biologics. It highlights the journey towards operational excellence through innovative implementations of an enterprise data lake with advanced analytics solutions, focusing on plasma pool efficiency and improvements, donor and plasma inventory management, yield prediction, manufacturing KPI monitoring, and application of Generative AI for enterprise search. The superior outcomes underscore significant advancements in production efficiency, data accessibility, and real-time decision-making processes.
Background
The necessity for innovation and efficiency in the biopharmaceutical industry is unprecedented, in light of unique challenges in manufacturing processes and regulatory demands. ADMA Biologics, in response, has engaged TCG Digital to leverage the mcube™ platform, aiming to revolutionize its manufacturing processes. This collaboration focuses on creating a data-driven decision-making ecosystem, addressing critical operational challenges, automating manual processes, and fostering a culture of continuous improvement and innovation.